Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias
AP Lea, D McTavish - Drugs, 1997 - Springer
Synopsis Atorvastatin is a synthetic HMG-CoA reductase inhibitor which lowers plasma
cholesterol levels by inhibiting endogenous cholesterol synthesis. It also reduces …
cholesterol levels by inhibiting endogenous cholesterol synthesis. It also reduces …
An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor
DM Black, RG Bakker-Arkema… - Archives of internal …, 1998 - jamanetwork.com
Background Statins (3-hydroxy-3-methylglutaryl–coenzyme A [HMG-CoA] reductase
inhibitors) have been used for a decade to lower low-density lipoprotein (LDL) cholesterol …
inhibitors) have been used for a decade to lower low-density lipoprotein (LDL) cholesterol …
[引用][C] Düşük çözünürlük gösteren ilaçların oral formülasyonları üzerine çalışmalar
M Diril - platform.almanhal.com
Al Manhal Platform The session has been expired. Please reload the page Reload Please
wait... The file is being prepared Preview Mode If you would like full access to this publication …
wait... The file is being prepared Preview Mode If you would like full access to this publication …